Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.
Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.
The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.
Publications found:
1,863
Sort by:
Global Prostate Cancer Therapeutics Market to 2020
US$ 1,200.00
... Decapeptyl 4. Eligard 5. Vantas 6. Leuplin Anti–Androgens 1. Casodex 2. Xtandi or MDV3100 3. Xtandi US or MDV3100 2. Global Prostate Cancer Chemotherapy Drugs Market 1. Taxotere 2. Jevtana 3. Global Prostate Cancer Immunotherapy Drugs Market– 1. Provenge 4. Global Prostate Cancer Targeted Therapy Drugs Market ...
November 2015
80 pages
KOL Insight: Prostate Cancer: Competition intensifies in race to the top
US$ 7,900.00
... Benefits Understand the Unique Benefits of KOL Insight: Prostate cancer Prostate Cancer: Competition intensifies in race to the top examines the most prominent insights gained from the field’s key ... performance of companies with the most robust new product pipelines Prostate Cancer: Competition intensifies in race to the top answers key questions including: How ...
October 2015
142 pages
Prostate Cancer: KOL Insight
US$ 7,495.00
... for market share? Prostate Cancer: KOL Insight looks at the future of prostate cancer therapy and provides insight from 12 leading North American and European KOLs. How will marketed ... co-administration a competitive disadvantage? And could it play a role in metastatic hormone-naïve prostate cancer? Pipeline Therapies Apalutamide (JNJ-927/ARN-509; Johnson & Johnson ...
October 2015
2016 World Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices - Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 27,600.00
... by country, section, market segment, and can be custom-tailored to your specific information needs and budget. '2016 World Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs ... and market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the ...
October 2015
1200 pages
2016 Italy Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial Labs - Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 5,360.00
... report is available by section, market segment, and can be custom-tailored to your specific information needs and budget. '2016 Italy Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial ... markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the ...
October 2015
570 pages
2016 US Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices - Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 7,840.00
... is available by section, market segment, and can be custom-tailored to your specific information needs and budget. '2016 US Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs ... markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the ...
October 2015
620 pages
Global Cervical Cancer Drugs Industry 2015 Market Research Report
US$ 2,850.00
2015 Global Cervical Cancer Drugs Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Cervical Cancer Drugs industry, focusing on the ... with: 1.) basic information; 2.) the Asia Cervical Cancer Drugs industry; 3.) the North American Cervical Cancer Drugs industry; 4.) the European Cervical Cancer Drugs industry; 5.) market entry and investment feasibility ...
October 2015
166 pages
2016 Emerging Strategies for the French Hospital Tumor Marker Testing Market
US$ 3,080.00
... market applications. Product development opportunities. Profiles of current and emerging suppliers, including their sales, market shares, product portfolios ... know-how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. ...
October 2015
533 pages
2016 Emerging Strategies for the German Hospital Tumor Marker Testing Market
US$ 3,080.00
... market applications. Product development opportunities. Profiles of current and emerging suppliers, including their sales, market shares, product portfolios ... know-how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. ...
October 2015
530 pages
2016 Emerging Strategies for the Italian Hospital Tumor Marker Testing Market
US$ 3,080.00
... market applications. Product development opportunities. Profiles of current and emerging suppliers, including their sales, market shares, product portfolios ... know-how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. ...
October 2015
525 pages
2016 Emerging Strategies for the Japanese Hospital Tumor Marker Testing Market
US$ 3,880.00
... market applications. Product development opportunities. Profiles of current and emerging suppliers, including their sales, market shares, product portfolios ... know-how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. ...
October 2015
537 pages
2016 Emerging Strategies for the Spanish Hospital Tumor Marker Testing Market
US$ 3,080.00
... market applications. Product development opportunities. Profiles of current and emerging suppliers, including their sales, market shares, product portfolios ... know-how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. ...
October 2015
521 pages
2016 Emerging Strategies for the UK Hospital Tumor Marker Testing Market
US$ 3,080.00
... market applications. Product development opportunities. Profiles of current and emerging suppliers, including their sales, market shares, product portfolios ... know-how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. ...
October 2015
527 pages
2016 Emerging Strategies for the US Hospital Tumor Marker Testing Market
US$ 5,200.00
... market applications. Product development opportunities. Profiles of current and emerging suppliers, including their sales, market shares, product portfolios ... know-how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. ...
October 2015
567 pages
2016 Opportunities in the World Cancer Diagnostics Market: Emerging Tests, Innovative Technologies, Instrumentation Review, Sales Forecasts by Country, Strategic Profiles of Leading Suppliers
US$ 6,000.00
This new report from VPGMarketResearch.com provides analysis of the global cancer diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers. The report presents: Estimated numbers of cancer testing laboratories, as ...
October 2015
510 pages
2016 World Tumor Marker and Special Chemistry Testing Market: Supplier Shares, Competitive Strategies, Country Segment Forecasts, Innovative Technologies, Instrumentation Review
US$ 6,800.00
... VPGMarketResearch.com contains 83 tables and provides analysis of the global tumor markers and special chemistry testing market, including emerging tests, technologies ... products, such as specimen preparation devices, controls, calibrators and others. '2016 World Tumor Marker and Special Chemistry Testing Market: Supplier Shares, Competitive Strategies ...
October 2015
320 pages
2015 CompetitiveWatch Cancer Diagnostics: Major Suppliers Strategic Assessments
US$ 2,000.00
This report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Contains 80 pages
October 2015
80 pages
2016 Emerging Cancer Diagnostic Tests, and Strategic Profile of Leading Reagent and Instrument Suppliers
US$ 3,080.00
... clinical significance and market needs for both current and emerging cancer diagnostic tests, as well as extensive listings of companies, universities and research centers developing ... applications. The report also presents strategic assessments of current and emerging suppliers of cancer diagnostic products, including their sales, product portfolios, distribution tactics ...
September 2015
286 pages
Cancer Immunotherapy: Payer Insight
US$ 7,495.00
... cancer immunotherapies. Payers believe that pharma companies do not properly appreciate their budget limitations. Reducing the costs of immunotherapy ...
September 2015
2015 World Cancer Diagnostics Market: Emerging Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Supplier Shares, Country Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review
US$ 27,800.00
... is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. '2015 World Cancer Diagnostics Market: Emerging Tumor Markers, Oncogenes ... and market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the ...
September 2015
1200 pages
